Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacep.2018.01.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Catheter ablation of atrial fibrillation after pericardiectomy: multi-center experience in China.
Ann Transl Med
May 2020
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Background: To study the effectiveness and safety of atrial fibrillation (AF) catheter ablation after pericardiectomy.
Methods: Data of 24 consecutive AF patients after pericardiectomy underwent catheter ablation from five centers were collected and analyzed retrospectively. All patients were followed up at 1, 3, and 12 months after catheter ablation.
Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban.
J Thromb Thrombolysis
August 2020
Department of Cardiology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, 920-0293, Japan.
Factor Xa (FXa) inhibitors are recommended for use in fixed doses without laboratory monitoring. However, prior studies reported the importance of establishing biomarkers representing anticoagulation intensity related to bleeding or thrombotic events. To test the hypothesis that prothrombin activation fragment 1 and 2 (F1 + 2), a non-specific marker of thrombin generation, could be altered during FXa inhibitor treatment in patients with atrial fibrillation.
View Article and Find Full Text PDFSame-day discharge in selected patients undergoing atrial fibrillation ablation.
Pacing Clin Electrophysiol
November 2019
Liverpool Heart And Chest Hospital, Liverpool, United Kingdom.
Background: Atrial fibrillation (AF) ablation is a complex procedure, generally requiring at least one overnight hospital stay. We investigated the safety and feasibility of early mobilization and same-day discharge following streamlined peri-ablation management for AF.
Methods: From 2014, we offered same-day discharge to selected patients who underwent uncomplicated AF ablation on the morning lists, with ultrasound-guided femoral access, uninterrupted warfarin or minimal interruption in novel oral anticoagulants, and reversal of intraprocedural heparin with protamine.
Stroke and thromboembolism prevention in atrial fibrillation.
Heart
January 2020
Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, USA
Prevention of stroke and systemic thromboembolism remains the cornerstone for management of atrial fibrillation (AF) and flutter. Multiple risk assessment models for stroke and systemic thromboembolism are currently available. The score, with its known limitations, remains as the recommended risk stratification tool in most major guidelines.
View Article and Find Full Text PDFUninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.
Clin Cardiol
January 2019
Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Catheter ablation has been established as a rhythm control strategy in selected patients with atrial fibrillation (AF) who have failed or wish to avoid anti-arrhythmic drugs. Uninterrupted oral anticoagulation with vitamin K antagonists (VKAs) peri-ablation is associated with a lower risk of thromboembolic and bleeding complications as compared to interrupted oral anticoagulation and bridging heparin. However, a substantial portion of patients with AF are treated with non-vitamin K antagonist oral anticoagulants (NOACs).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!